Why Iron? Iron is the Most prevalent micronutrient deficiency in the world (WHO 1968)

Similar documents
Iron infusions in the community

Post-operative and Discharge Pathways for PBM Claire L J Atterbury CNS Transfusion and Haematology

PATIENT GROUP DIRECTION (PGD) FOR THE

INAPPROPRIATE BLOOD REQUESTS:

Competency Assessment for Non Medical Prescribing of Blood and Blood Components

PROTOCOL FOR THE ADMINISTRATION OF SENNA. Formulary and Prescribing Guidelines

PROTOCOL FOR VENESECTION

National clinical audit of inpatient care for adults with ulcerative colitis

Standard Operating Procedure for Patients Referred for Blood Transfusion to Louth Clinical Decision Unit by General Practitioners.

Patient Blood Management An Overview. Denise Watson Patient Blood Management Practitioner 11 th January, 2016

Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee

User Guide for Patients

Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment

Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version

Implementation Guide Single Unit Transfusion Policy

Patient Blood Management Certification Revisions

Medicines Reconciliation Policy

Cyclophosphamide INFUSION Infusion 4 Plus

2018 Optional Special Interest Groups

Aranesp (Darbepoetin) for Renal Anaemia

MINNESOTA. Downloaded January 2011

Reducing medicines waste in Care Settings.

All Wales Multidisciplinary Medicines Reconciliation Policy

Non-Medical Prescribing Passport. Reflective Log And Information

Actelion Pharmaceuticals US is proud to be the 2011 National Gold Sponsor of the Scleroderma Foundation

Improving compliance with oral methotrexate guidelines. Action for the NHS

Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

5. returning the medication container to proper secured storage; and

Section 7: Core clinical headings

Inflammatory bowel disease service. Information for patients

Medical Staff Rules & Regulations Last Updated: October University Hospital Medical Staff. Rules & Regulations

PACES Station 2: HISTORY TAKING

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

Anaphylactic Reaction Emergency Treatment Reference Number:

MALNUTRITION UNIVERSAL SCREEING TOOL (MUST) MUST IS A MUST FOR ALL PATIENTS

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement

Managing medicines in care homes

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

SUPPLY BY PHARMACISTS OF A NON-PRESCRIPTION MEDICINAL PRODUCT CONTAINING LEVONORGESTREL (NORLEVO 1.5MG TABLETS) AS EMERGENCY HORMONAL CONTRACEPTION

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Administering Medicine Policy

SOP Venesection Registered Nurses

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

PRESCRIBING SUPPORT TECHNICIAN:

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

MEDICINES RECONCILIATION GUIDELINE Document Reference

OPAT CELLULITIS PATHWAY

THE DAY OF YOUR SURGERY

Aldijana Avdić, BSN, RN, PBMS, CPHQ Assistant Director, Patient Safety and Privacy 1

Outpatient Services Improvement September 2010

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM WEEKLY RITUXIMAB. Patient s first names. Date of birth

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)

Outcomes from the Business Case Sub Committee 8 th February 2013

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Community Intravenous Therapy Referral Standards

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

Section 6: Referral record headings

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

The University Hospital Medical Staff. Rules And Regulations

2. Short term prescription medication and drugs (administered for less than two weeks):

The hospital s anesthesia services must be integrated into the hospital-wide QAPI program.

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Bowel Screening Wales Information booklet for care homes and associated health professionals. Available in other formats on request. October.14.v.2.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

Document Details. notification of entry onto webpage

Presented by Copyright 2013, all rights reserved

Medicines Reconciliation: Standard Operating Procedure

AREAS OF RESPONSIBILITY

Patient Controlled Analgesia Guidelines

PREPARATION AND ADMINISTRATION

Reducing errors with epma electronic Prescribing and Medicines Administration. Stockport NHS Foundation Trust December 2013

Urgent Treatment Centres Principles and Standards

Receiving a transfusion

GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION. Version 5 December 2017

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Evaluation of the Hywel Dda Community Pharmacist pilot optimising medicines treatment in heart failure.

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

ADMINISTRATION OF MEDICATION BY DELEGATION

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

Job Title Name Signature Date

Standards for side effect monitoring

Name Job Title Signed Date

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

Safe Blood Transfusion

Influence of Patient Flow on Quality Care

Malcolm Robinson Chief BMS, WSHT, and Chair of SE Thames TA(D)G

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS

Expiry Date: January 2009 Template Version: Page 1 of 7

To understand the formulary process from the hospital perspective

Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.

Trust Policy for Blood Transfusion

The use of Homely Remedies in Care Homes

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure

Transcription:

Why Iron? Iron is the Most prevalent micronutrient deficiency in the world (WHO 1968) Iron deficiency anaemia is a Major reason for blood being transfused Iron deficiency without anaemia is 3 times as common as Iron deficiency anaemia (Ionnou.GN, Rockas.D et al 2002) Red cell transfusion will not fully replenish diminished iron stores in iron deficient patients, only addressing the acute symptoms of anaemia

Blood management? Department of Health(2002)Health Service Circular 2002/009 Better Blood Transfusion- Safe and Appropriate use of Blood Patient Blood management initiatives NCA 2011 Audit of the Use of blood in adult medical patients part 1 identified 13% of patients transfused as potentially iron deficient. Alternative treatment for those choosing not to have blood

How does Iron fit into pre-op preparation? Studies have identified about 35% (ranging from 20-70%) of pre-op patients as anaemic and a third of those as suffering from iron deficiency (Goodhough.L et al 2008), (Bisbe.E et al 2008), (Salah.E et al 2007) HSC Better Blood Transfusion and NICE guidelines state Hospitals have a duty to assess patients pre-operatively, and patients considered anaemic should have their haemoglobin optimised prior to surgery, which may involve intravenous (IV) iron if appropriate. Haematinic deficiency without anaemia may blunt the recovery from postoperative anaemia. The early detection & treatment may reduce the need for transfusion and its negative consequences (Bishe.E, Minoz.M 2012) Recommendation in the NATA consensus statement that IV Iron is administered pre-operatively for patients undergoing orthopaedic surgery expected to develop severe post-op anaemia Future planned pre-operative audits and guidance likely to increase awareness and demand Currently the PREVENTT study is taking place to look at the efficacy of IV Iron in major abdominal surgery.

Iron deficiency Evidence of Iron deficiency anaemia Low Hb Low ferritin Low serum iron Transferrin saturation usually <10 Microcytosis Hypochromia Evidence of functional iron deficiency Normal or high ferritin Transferrin saturation usually <20% Reduced MCV Hypochromia Increased reticulocytes Management All patients should have iron supplementation both to correct anaemia & replenish body stores Parental Iron can be used when oral preparations are not tolerated (Goddarard.a, James.M et al 2005)

Comparison of Iron Preparations Oral Advantages Cheap convenient Disadvantages Slow uptake GI Intolerance limited absorption Patient compliance IM Ease of administration High risk of adverse events Patient discomfort IV Rapid effect v s oral iron Higher doses can be administered Can be given as total dose Improved safety of newer preparations Higher cost Administration by health care professional Risk of adverse events

IV Iron 4 preparations No longer a requirement for a test dose with IV Iron (MHRA Aug 2013) Product Iron Dextran (Cosmofer) Ferric Carboxymaltose (ferinject) Maximum total Dose Total dose infusion Infusion time 1600mg Yes 6 hours 1000mg Yes 15 mins Iron Maltoside (monofer) 1600mg Yes 1 hour Iron Sucrose (Venofer) 200mg No 15min

Appropriate treatment for Iron deficiency More economical Less associated risk Avoids the risk of patient incompatibility Readily stored Less regulation! Longer shelf-life IV Iron V s Red cells Some preparations now offer a much faster treatment time than red cell transfusion Option for patients who wish to avoid blood Can also be used in combination with red cell transfusion to reduce transfusion requirement in patients requiring regular transfusion support.

Now how do we go about delivering it?

The Need for a Formalised Service Appropriate framework Who will decide if IV iron is necessary? Who will prescribe it? Who / where to administer it? Who will perform follow up? Patient information ensure patient confidence in service

The key to making it work An efficient process from start to finish Simple Straight forward Referrals Admissions Prescriptions Dedicated infusion area Information for staff and patients Standard Follow up

How we do it The Nurse led Service; Frees up Consultant time Reduces waiting time Appropriate use of specialist nurse skills & knowledge Consultant Back up if required Utilisation of PGD s for prescriptions Use of Protocols Information Improved access day case admission, not in-patient care Acute admission reductions & financial savings

The Referral Flow chart for the use of IV iron i.e. ensuring appropriate referrals Designated referral form (internal) Recent blood results Referred to me GP referrals : Initial referral sent to Consultant, subsequent admissions arranged by me

Treatment flow chart for iron deficiency anaemia once investigations for cause are complete

REFERRAL FOR TREATMENT WITH INTRAVENOUS IRON Patient name Patient DOB Patient hospital number Name of referring physician Contact number (bleep/secretary) Recent blood results Date Hb Hct MCV MCH Iron Transferrin Transferrin saturation Ferritin Weight (kg) Has iron deficiency been investigated? Yes No Reason for iron deficiency if known - Has the patient been given oral iron? Yes No Why is the patient being referred for IV iron? Has the patient previously had IV iron? Yes No Other relevant information Send referral to Frances Sear Transfusion Practitioner frances.sear@nhs.net or C/O Pathology office THE PATIENT WILL REMAIN UNDER THE CARE OF THE REFERRING PHYSICIAN

Admission Upon referral patients are contacted by myself for medical history including weight & allergies, explanation of procedure and choices of treatment Consent to be treated under the patient group directive. All documented in their medical records Admission is then arranged. Aim is to get all patients treated within 1-4 weeks of referral. Admitted to dedicated infusion suite as a day case ; Dedicated unit with trained staff Full facilities for CPR and anaphylaxis management for dealing with potential adverse reactions

The Prescription At the beginning a lot of running around to find a doctor who didn't know the patient, would never meet the patient, didn t know the drug so had to be told what to write! Now..

The Patient Group Directive (PGD) PGD, approved by physicians and pharmacy, - a set of criteria under which the patient can be treated. for total dose infusion of iron Dextran (CosmoFer). Dosed according to weight and current/ target Hb 130g/L we use a target of for repeated dose iron sucrose (VenoFer) If a patient does not meet the criteria of the PGD they can still receive IV Iron under the direction of a consultant.

What Influences the Choice of Preparation? Patient choice length of stay, frequency of visits, usually to fit around work commitments Medical history Venofer 1 st choice for patients with history of severe / multiple allergy Admission slots available Time to scheduled surgery

Information, Information, Information Dedicated section on the hospital intranet for the IV Iron service accessible and accurate information available to all staff at all times. Referral form and flow chart Full Protocols for both Cosmofer and Venofer detailing indications, dosage table, administration Nursing Care Plans Patient information with contact number

Protocols Individual protocol developed for each product Based on manufacturers guidance and current research Enabled all staff access to the information they needed for prescribing and administering IV Iron enables the same treatment to be given to inpatients/obstetrics by medical staff

The protocols detail; General information, IV Iron preparations available and response to products Investigations required & flowchart for IV Iron use Clinical indications, contraindications and cautions Dosage table and guidelines on how to select the correct dose Guidelines for administration, including patient monitoring, side effects and treatment and management of adverse events Guidelines for obstetric use - ante-natal and post-natal Follow -up

Follow up Patients given forms for blood tests 3 weeks post infusion ( or pre-op if sooner) Follow up letter with results sent to patient and GP/hospital consultant No further routine follow up but advised to contact GP if symptoms related to anaemia arise in the future Patients who have had Iron pre-operatively often find the cause for anaemia is resolved by the surgery they have had - no further treatment required. A number of patients receive regular infusions and are monitored by myself and/or their consultants and brought in when their Iron levels begin to drop.

Case study 1 Male 43 years old Ulcerative Colitis previous Colectomy Unable to tolerate oral Iron, issues around malabsorption. Symptomatic affecting work and home life Previously transfused Brought in for Cosmofer total dose infusion Good response to treatment now has regular infusions every 5-6 months Has had 3 operations with Cosmofer infusions pre-operatively to optimise haemoglobin prior to surgery.

Pre Cosmofer infusion Post Hb 95 125 HCT 0.32 0.4 MCV 65 74 MCH 19.8 22.9 Iron 1.8 9 Transferrin 2.7 2.1 Transferrin Saturation 3 17 Ferritin 6 43

Case study 2 Male 47 years Complex medical history MDS refused all treatment, Hb averaged 20-30g/L for over 1 year. V. Poor quality of life Finally agreed to have an Iron infusion still refused blood. Now has regular iron infusions every 8-12 weeks and maintains his Hb between 80 and130g/ L

Pre Cosmofer infusion Post Hb 24 83 HCT 0.26 0.38 MCV 49 65 MCH 12 19.3 Iron <1 2.6 Transferrin 2.5 1.8 Transferrin Saturation 6 Ferritin <1 52

Results Rise in Hb Rise in Ferritin

Activity summary Nurse led service only (does not include inpatient treatment or obstetrics) Over 200 new patient referrals Over 20 regular patients receiving infusions anything from every 8 weeks 9 months Activity increasing as awareness of service, and issues of appropriate treatment grow The majority of our patients are in gastroenterology( IBD), Haematology, gynaecology, pre-operative patients and Obstetrics ( manage their own case load)

The Good, The Bad, The Ugly

The Good Appropriate treatment Saved.. Red cells Alternative treatment option for patients who refuse blood Meets the objectives of Better Blood Transfusion & PBM Efficient service for iron deficient patients for whom oral iron isn t an option or quick treatment is required The Bad & The Ugly Beware of being a victim of your own success! Be realistic with capacity and patient throughput Staffing to cover the service during periods of leave Try and use a quick total dose infusion to make patient stay shorter, avoid capacity issues & improve patient experience

The boring important stuff Audit Re-evaluation of the service identify problems and put in solutions Quick simple fixes = big changes Admissions times of unit changed from 09.00-08.00 capacity. more flexibility with Stock holding of IV Iron on unit previous delays of up to 90 minutes waiting for prescriptions from pharmacy. The use of short notice cancellation slots Income generation from the service-importance of the correct coding

The future Currently we are limited by the number of outpatients we can admit due to capacity and staffing of the infusion suite. Reduced patient stay would allow more patients to be admitted. Plan; Audit of service Look at introduction of a quick total dose IV Iron Decreased infusion time equals increased capacity for patients and decreased cost to the Trust, increased potential throughput and income

Conclusion Appropriate treatment for patients Decrease in red cell usage Financial savings -Cheaper than red cells Avoids inpatient hospital admission and inappropriate transfusion An alternative treatment for patients who refuse blood -the service has been adopted and promoted by our Jehovah s Witness liaison committee and their members Increased awareness of Iron deficiency anaemia and the appropriate treatment of it.

Why we really do this